Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$63.98 - $85.37 $313,118 - $417,800
4,894 New
4,894 $358,000
Q2 2022

Aug 10, 2022

SELL
$56.6 - $89.9 $195,043 - $309,795
-3,446 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$60.15 - $84.52 $207,276 - $291,255
3,446 New
3,446 $286,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.